For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $322.79 in the prior trading day, Celestica, Inc (NYSE: CLS) closed at $325.09, up 0.71%. In other words, the price has increased by $0.71 from its previous closing price. On the day, 1.39 million shares were traded. CLS stock price reached its highest trading level at $327.95 during the session, while it also had its lowest trading level at $320.62.
Ratios:
Our goal is to gain a better understanding of CLS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 122.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 94.10. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.43.
On October 16, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $340.
TD Securities Downgraded its Buy to Hold on October 03, 2025, while the target price for the stock was maintained at $238.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’25 when Wong Leila sold 3,160 shares for $323.38 per share. The transaction valued at 1,021,881 led to the insider holds 13,892 shares of the business.
Etienvre Yann L sold 9,187 shares of CLS for $2,970,892 on Dec 01 ’25. The Chief Operations Officer now owns 0 shares after completing the transaction at $323.38 per share. On Dec 01 ’25, another insider, Wong Leila, who serves as the Officer of the company, bought 3,160 shares for $344.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 37397254144 and an Enterprise Value of 37876953088. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 52.76, and their Forward P/E ratio for the next fiscal year is 38.60. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.31 while its Price-to-Book (P/B) ratio in mrq is 18.43. Its current Enterprise Value per Revenue stands at 3.357 whereas that against EBITDA is 34.019.
Stock Price History:
The Beta on a monthly basis for CLS is 1.87, which has changed by 2.5953329 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $363.40, while it has fallen to a 52-week low of $58.05. The 50-Day Moving Average of the stock is 9.95%, while the 200-Day Moving Average is calculated to be 80.23%.
Shares Statistics:
The stock has traded on average 3.16M shares per day over the past 3-months and 2990880 shares per day over the last 10 days, according to various share statistics. A total of 115.00M shares are outstanding, with a floating share count of 114.35M. Insiders hold about 0.52% of the company’s shares, while institutions hold 73.36% stake in the company. Shares short for CLS as of 1763078400 were 3389445 with a Short Ratio of 1.07, compared to 1760486400 on 5021778. Therefore, it implies a Short% of Shares Outstanding of 3389445 and a Short% of Float of 2.96.
Earnings Estimates
The company has 16.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $1.83, with high estimates of $2.02 and low estimates of $1.69.
Analysts are recommending an EPS of between $6.05 and $5.84 for the fiscal current year, implying an average EPS of $5.93. EPS for the following year is $8.38, with 16.0 analysts recommending between $9.27 and $8.19.
Revenue Estimates
14 analysts predict $3.49B in revenue for. The current quarter. It ranges from a high estimate of $3.62B to a low estimate of $3.35B. As of. The current estimate, Celestica, Inc’s year-ago sales were $2.55BFor the next quarter, 14 analysts are estimating revenue of $3.6B. There is a high estimate of $3.83B for the next quarter, whereas the lowest estimate is $3.49B.
A total of 16 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.35B, while the lowest revenue estimate was $12.09B, resulting in an average revenue estimate of $12.22B. In the same quarter a year ago, actual revenue was $9.65BBased on 16 analysts’ estimates, the company’s revenue will be $16.24B in the next fiscal year. The high estimate is $17.06B and the low estimate is $15.96B.
